F-氟米索硝唑（FMISO）正电子发射断层扫描（PET）可能具有检测心脏结节病的潜力。
F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis.
作者信息
Manabe Osamu, Hirata Kenji, Shozo Okamoto, Shiga Tohru, Uchiyama Yuko, Kobayashi Kentaro, Watanabe Shiro, Toyonaga Takuya, Kikuchi Hisaya, Oyama-Manabe Noriko, Tamaki Nagara
机构信息
Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Kita-15 Nishi-7, Kita-Ku, Sapporo, Hokkaido, 060-8638, Japan.
Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Japan.
出版信息
J Nucl Cardiol. 2017 Feb;24(1):329-331. doi: 10.1007/s12350-016-0495-2. Epub 2016 Apr 12.
F-fluoromisonidazole (FMISO) is a positron emission tomography (PET) tracer that accumulates in hypoxic tissues. We here present a case of suspected cardiac sarcoidosis which was detected with increased FMISO uptake.
氟代米索硝唑（FMISO）是一种正电子发射断层扫描（PET）示踪剂，可在缺氧组织中蓄积。我们在此报告一例疑似心脏结节病的病例，该病例通过FMISO摄取增加得以检测出来。
Zotero 插件